PATIENT AI Act Discussion Draft, AMA Issue Brief for Clinical AI Liability Released
Accountability and reimbursement for artificial intelligence (AI)-based technologies were highlighted topics of discussion last week.
1 min read
brandon.rakes May 19, 2025
The Association for Diagnostics & Laboratory Medicine (ADLM) urged the Department of Health and Human Service (HHS) to reinstate the Clinical Laboratory Improvements Advisory Committee (CLIAC) in a May 14 letter to HHS Secretary Robert F. Kennedy, Jr.
In a press release, ADLM blamed the elimination of CLIAC for the laboratory medicine community’s loss of “its premier forum for ensuring that the regulations for clinical labs continue to meet the changing needs of the health care community,” especially as many call for the modernization of the Clinical Laboratory Improvement Amendments (CLIA).
CLIAC was chartered by HHS in 1992 and has since provided “scientific and technical advice and guidance” on issues involving CLIA regulations, according to ADLM. Among those issues were testing quality, personnel requirements, and proficiency testing frequency.
The decision to eliminate CLIAC is one part of the aggressive restructuring of the department under the Trump administration. ADLM points out, however, that because the CLIA program is funded by $80 million in user fees from the laboratory community, with a portion of that funding supporting CLIAC, any government cost savings from the elimination would therefore be negligible.
Sources:
https://myadlm.org/advocacy-and-outreach/comment-letters/2025/hhs-cliac-final

Accountability and reimbursement for artificial intelligence (AI)-based technologies were highlighted topics of discussion last week.
Lincoln, NE – November 2026 TELCOR is proud to announce the promotion of Stephanie Gonnerman to Senior Analyst, Revenue Cycle Management (RCM).
The Centers for Medicare and Medicaid Services (CMS) released a report on Oct. 20 detailing significant differences in the share of reported test...